JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, cilt.26, sa.1, ss.7-13, 2020 (SCI-Expanded)
Objective: We aimed to present our single-center real-life experience of canakinumab use in adult patients with familial Mediterranean fever (FMF).